Latest News about MNMD
Recent news which mentions MNMD
Combining MDMA With Psilocybin Or LSD Could Reduce Difficult Trips, New Study Shows
September 13, 2023
Tickers
MNMD
From Benzinga
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years
September 12, 2023
From Benzinga
MindMed's Phase 2b Trial For MM-120 In GAD Reaches Enrollment Milestone
September 12, 2023
Tickers
MNMD
From Benzinga
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
September 11, 2023
From Benzinga
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
September 05, 2023
From Benzinga
Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More
August 28, 2023
From Benzinga
Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
August 21, 2023
From Benzinga
MindMed Inks $50M Credit Facility Deal With K2 HealthVentures For An Additional Operational Year
August 14, 2023
Tickers
MNMD
From Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
August 14, 2023
From Benzinga
MindMed's Q2 2023: One Of Biggest Players In The Space Sustains Faith In LSD's Multiple Path Ahead
August 07, 2023
Tickers
MNMD
From Benzinga
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
August 03, 2023
From Benzinga
From Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 18, 2023
From Benzinga
From Benzinga
The 3 Best Psychedelic Stocks to Buy Now
June 29, 2023
From InvestorPlace
MindMed Shareholders Vote For All Six Company Nominees At Annual Meeting, Current R&D Path Upheld
June 27, 2023
Tickers
MNMD
From Benzinga
TOMS Shoes founder is pledging $100 million for psychedelic research – Here’s why he’s doing it.
June 21, 2023
From MarketWatch
From Benzinga
From Benzinga
From Benzinga
From Benzinga
MindMed's LSD Study For Anxiety Treatment Enrolls And Doses 100 Participants, More Expected
May 19, 2023
Tickers
MNMD
From Benzinga
FCM Holdings Accuse MindMed Braintrust Of 'Pursuing Misguided Clinical Path for MM-120'
May 16, 2023
Tickers
MNMD
From Benzinga
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
May 08, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.